Muscle Monitoring and Maintenance as an End Point for Patients Treated for Cancer

Clin Oncol (R Coll Radiol). 2015 Aug;27(8):479-81. doi: 10.1016/j.clon.2015.04.035. Epub 2015 May 21.

Authors

G Malietzis¹, N Anyamene², J T Jenkins³

Affiliations

¹ Department of Surgery, St Mark's Hospital, Harrow, UK; Department of Surgery and Cancer, Imperial College, London, UK.
² Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex, UK.
³ Department of Surgery, St Mark's Hospital, Harrow, UK; Department of Surgery and Cancer, Imperial College, London, UK. Electronic address: i.jenkins@nhs.net.

PMID: 26004239
DOI: 10.1016/j.clon.2015.04.035

No abstract available

Publication types

Editorial

MeSH terms

Endpoint Determination
Humans
Muscle, Skeletal / physiopathology*
Muscular Atrophy / etiology
Muscular Atrophy / physiopathology
Muscular Atrophy / prevention & control*
Muscular Atrophy / rehabilitation
Neoplasms / complications*
Neoplasms / physiopathology
Neoplasms / therapy